目次

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Drug Class
1.2.2. Type
1.2.3. Route of Administration
1.2.4. Regional scope
1.2.5. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. GVR’s internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives

Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Drug Class outlook
2.2.2. Type outlook
2.2.3. Route of Administration
2.2.4. Regional outlook
2.3. Competitive Insights

Chapter 3. Psoriatic Arthritis Treatment Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.2. Market restraint analysis
3.3. Psoriatic Arthritis Treatment Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape

Chapter 4. Psoriatic Arthritis Treatment Market: Drug Class Estimates & Trend Analysis
4.1. Drug Class Segment Dashboard
4.2. Psoriatic Arthritis Treatment Market: Drug Class Movement Analysis
4.3. Global Psoriatic Arthritis Treatment Market Size & Trend Analysis, by Drug Class, 2018 to 2030 (USD Million)
4.4. NSAIDs
4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.5. DMARDs
4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.6. Biologics
4.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.7. Others
4.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Psoriatic Arthritis Treatment Market: Type Estimates & Trend Analysis
5.1. Type Segment Dashboard
5.2. Psoriatic Arthritis Treatment Market: Type Movement Analysis
5.3. Global Psoriatic Arthritis Treatment Market Size & Trend Analysis, by Type, 2018 to 2030 (USD Million)
5.4. Prescriptions
5.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.5. OTC
5.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Psoriatic Arthritis Treatment Market: Route of Administration Estimates & Trend Analysis
6.1. Route of Administration Segment Dashboard
6.2. Psoriatic Arthritis Treatment Market: Route of Administration Movement Analysis
6.3. Global Psoriatic Arthritis Treatment Market Size & Trend Analysis, by Route of Administration, 2018 to 2030 (USD Million)
6.4. Topical
6.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
6.5. Oral
6.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
6.6. Injectable
6.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Psoriatic Arthritis Treatment Market: Regional Estimates & Trend Analysis
7.1. Regional Market Dashboard
7.2. Regional Market Share Analysis, 2024 & 2030
7.3. Continuous bioprocessing market by Region: Key Takeaways
7.4. North America
7.4.1. U.S.
7.4.1.1. Key country dynamics
7.4.1.2. Regulatory framework/ reimbursement structure
7.4.1.3. Competitive scenario
7.4.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
7.4.2. Canada
7.4.2.1. Key country dynamics
7.4.2.2. Regulatory framework/ reimbursement structure
7.4.2.3. Competitive scenario
7.4.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
7.5. Europe
7.5.1. UK
7.5.1.1. Key country dynamics
7.5.1.2. Regulatory framework/ reimbursement structure
7.5.1.3. Competitive scenario
7.5.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
7.5.2. Germany
7.5.2.1. Key country dynamics
7.5.2.2. Regulatory framework/ reimbursement structure
7.5.2.3. Competitive scenario
7.5.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
7.5.3. France
7.5.3.1. Key country dynamics
7.5.3.2. Regulatory framework/ reimbursement structure
7.5.3.3. Competitive scenario
7.5.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
7.5.4. Italy
7.5.4.1. Key country dynamics
7.5.4.2. Regulatory framework/ reimbursement structure
7.5.4.3. Competitive scenario
7.5.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
7.5.5. Spain
7.5.5.1. Key country dynamics
7.5.5.2. Regulatory framework/ reimbursement structure
7.5.5.3. Competitive scenario
7.5.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
7.6. Asia Pacific
7.6.1. Japan
7.6.1.1. Key country dynamics
7.6.1.2. Regulatory framework/ reimbursement structure
7.6.1.3. Competitive scenario
7.6.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
7.6.2. China
7.6.2.1. Key country dynamics
7.6.2.2. Regulatory framework/ reimbursement structure
7.6.2.3. Competitive scenario
7.6.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
7.6.3. India
7.6.3.1. Key country dynamics
7.6.3.2. Regulatory framework/ reimbursement structure
7.6.3.3. Competitive scenario
7.6.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
7.6.4. Australia
7.6.4.1. Key country dynamics
7.6.4.2. Regulatory framework/ reimbursement structure
7.6.4.3. Competitive scenario
7.6.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
7.6.5. South Korea
7.6.5.1. Key country dynamics
7.6.5.2. Regulatory framework/ reimbursement structure
7.6.5.3. Competitive scenario
7.6.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
7.7. Latin America
7.7.1. Brazil
7.7.1.1. Key country dynamics
7.7.1.2. Regulatory framework/ reimbursement structure
7.7.1.3. Competitive scenario
7.7.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
7.7.2. Argentina
7.7.2.1. Key country dynamics
7.7.2.2. Regulatory framework/ reimbursement structure
7.7.2.3. Competitive scenario
7.7.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
7.8. MEA
7.8.1. South Africa
7.8.1.1. Key country dynamics
7.8.1.2. Regulatory framework/ reimbursement structure
7.8.1.3. Competitive scenario
7.8.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
7.8.2. Saudi Arabia
7.8.2.1. Key country dynamics
7.8.2.2. Regulatory framework/ reimbursement structure
7.8.2.3. Competitive scenario
7.8.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
7.8.3. UAE
7.8.3.1. Key country dynamics
7.8.3.2. Regulatory framework/ reimbursement structure
7.8.3.3. Competitive scenario
7.8.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape
8.1. Recent Developments & Impact Analysis, By Key Market Participants
8.2. Company/Competition Categorization
8.3. Vendor Landscape
8.3.1. Key company heat map analysis, 2024
8.4. Company Profiles
8.4.1. AbbVie Inc.
8.4.1.1. Company overview
8.4.1.2. Financial performance
8.4.1.3. Product benchmarking
8.4.1.4. Strategic initiatives
8.4.2. Amgen Inc.
8.4.2.1. Company overview
8.4.2.2. Financial performance
8.4.2.3. Product benchmarking
8.4.2.4. Strategic initiatives
8.4.3. Johnson & Johnson Services, Inc.
8.4.3.1. Company overview
8.4.3.2. Financial performance
8.4.3.3. Product benchmarking
8.4.3.4. Strategic initiatives
8.4.4. Bristol-Myers Squibb Company
8.4.4.1. Company overview
8.4.4.2. Financial performance
8.4.4.3. Product benchmarking
8.4.4.4. Strategic initiatives
8.4.5. Novartis AG
8.4.5.1. Company overview
8.4.5.2. Financial performance
8.4.5.3. Product benchmarking
8.4.5.4. Strategic initiatives
8.4.6. Eli Lilly and Company
8.4.6.1. Company overview
8.4.6.2. Financial performance
8.4.6.3. Product benchmarking
8.4.6.4. Strategic initiatives
8.4.7. Pfizer, Inc.
8.4.7.1. Company overview
8.4.7.2. Financial performance
8.4.7.3. Product benchmarking
8.4.7.4. Strategic initiatives
8.4.8. UCB S.A.
8.4.8.1. Company overview
8.4.8.2. Financial performance
8.4.8.3. Product benchmarking
8.4.8.4. Strategic initiatives

List of Tables
Table 1 List of abbreviations
Table 2 Global psoriatic arthritis treatment market, by region (USD Million) 2018 - 2030
Table 3 Global psoriatic arthritis treatment market, by drug class (USD Million) 2018 - 2030
Table 4 Global psoriatic arthritis treatment market, by type (USD Million) 2018 - 2030
Table 5 Global psoriatic arthritis treatment market, by route of administration (USD Million) 2018 - 2030
Table 6 North America psoriatic arthritis treatment market, by country (USD Million) 2018 - 2030
Table 7 North America psoriatic arthritis treatment market, by drug class (USD Million) 2018 - 2030
Table 8 North America psoriatic arthritis treatment market, by type (USD Million) 2018 - 2030
Table 9 North America psoriatic arthritis treatment market, by route of administration (USD Million) 2018 - 2030
Table 10 U.S. psoriatic arthritis treatment market, by drug class (USD Million) 2018 - 2030
Table 11 U.S. psoriatic arthritis treatment market, by type (USD Million) 2018 - 2030
Table 12 U.S. psoriatic arthritis treatment market, by route of administration (USD Million) 2018 - 2030
Table 13 Canada psoriatic arthritis treatment market, by drug class (USD Million) 2018 - 2030
Table 14 Canada psoriatic arthritis treatment market, by type (USD Million) 2018 - 2030
Table 15 Canada psoriatic arthritis treatment market, by route of administration (USD Million) 2018 - 2030
Table 16 Mexico psoriatic arthritis treatment market, by drug class (USD Million) 2018 - 2030
Table 17 Mexico psoriatic arthritis treatment market, by type (USD Million) 2018 - 2030
Table 18 Mexico surgical ablation market, by route of administration (USD Million) 2018 - 2030
Table 19 Europe psoriatic arthritis treatment market, by country (USD Million) 2018 - 2030
Table 20 Europe psoriatic arthritis treatment market, by drug class (USD Million) 2018 - 2030
Table 21 Europe psoriatic arthritis treatment market, by type (USD Million) 2018 - 2030
Table 22 Europe psoriatic arthritis treatment market, by route of administration (USD Million) 2018 - 2030
Table 23 Germany psoriatic arthritis treatment market, by drug class (USD Million) 2018 - 2030
Table 24 Germany psoriatic arthritis treatment market, by type (USD Million) 2018 - 2030
Table 25 Germany psoriatic arthritis treatment market, by route of administration (USD Million) 2018 - 2030
Table 26 UK psoriatic arthritis treatment market, by drug class (USD Million) 2018 - 2030
Table 27 UK psoriatic arthritis treatment market, by type (USD Million) 2018 - 2030
Table 28 UK psoriatic arthritis treatment market, by route of administration (USD Million) 2018 - 2030
Table 29 France psoriatic arthritis treatment market, by drug class (USD Million) 2018 - 2030
Table 30 France psoriatic arthritis treatment market, by type (USD Million) 2018 - 2030
Table 31 France psoriatic arthritis treatment market, by route of administration (USD Million) 2018 - 2030
Table 32 Italy psoriatic arthritis treatment market, by drug class (USD Million) 2018 - 2030
Table 33 Italy psoriatic arthritis treatment market, by type (USD Million) 2018 - 2030
Table 34 Italy psoriatic arthritis treatment market, by route of administration (USD Million) 2018 - 2030
Table 35 Spain psoriatic arthritis treatment market, by drug class (USD Million) 2018 - 2030
Table 36 Spain psoriatic arthritis treatment market, by type (USD Million) 2018 - 2030
Table 37 Spain psoriatic arthritis treatment market, by route of administration (USD Million) 2018 - 2030
Table 38 Asia Pacific psoriatic arthritis treatment market, by country (USD Million) 2018 - 2030
Table 39 Asia Pacific psoriatic arthritis treatment market, by drug class (USD Million) 2018 - 2030
Table 40 Asia Pacific psoriatic arthritis treatment market, by type (USD Million) 2018 - 2030
Table 41 Asia Pacific psoriatic arthritis treatment market, by route of administration (USD Million) 2018 - 2030
Table 42 China psoriatic arthritis treatment market, by drug class (USD Million) 2018 - 2030
Table 43 China psoriatic arthritis treatment market, by type (USD Million) 2018 - 2030
Table 44 China psoriatic arthritis treatment market, by route of administration (USD Million) 2018 - 2030
Table 45 Japan psoriatic arthritis treatment market, by drug class (USD Million) 2018 - 2030
Table 46 Japan psoriatic arthritis treatment market, by type (USD Million) 2018 - 2030
Table 47 Japan psoriatic arthritis treatment market, by route of administration (USD Million) 2018 - 2030
Table 48 India psoriatic arthritis treatment market, by drug class (USD Million) 2018 - 2030
Table 49 India psoriatic arthritis treatment market, by type (USD Million) 2018 - 2030
Table 50 India psoriatic arthritis treatment market, by route of administration (USD Million) 2018 - 2030
Table 51 South Korea psoriatic arthritis treatment market, by drug class (USD Million) 2018 - 2030
Table 52 South Korea psoriatic arthritis treatment market, by type (USD Million) 2018 - 2030
Table 53 South Korea psoriatic arthritis treatment market, by route of administration (USD Million) 2018 - 2030
Table 54 Australia psoriatic arthritis treatment market, by drug class (USD Million) 2018 - 2030
Table 55 Australia psoriatic arthritis treatment market, by type (USD Million) 2018 - 2030
Table 56 Australia psoriatic arthritis treatment market, by route of administration (USD Million) 2018 - 2030
Table 57 Latin America psoriatic arthritis treatment market, by country (USD Million) 2018 - 2030
Table 58 Latin America psoriatic arthritis treatment market, by drug class (USD Million) 2018 - 2030
Table 59 Latin America surgical ablation market, by type (USD Million) 2018 - 2030
Table 60 Latin America laparoscopic ablation market, by route of administration (USD Million) 2018 - 2030
Table 61 Latin America percutaneous ablation market, by route of administration (USD Million) 2018 - 2030
Table 62 Latin America psoriatic arthritis treatment market, by route of administration (USD Million) 2018 - 2030
Table 63 Brazil psoriatic arthritis treatment market, by drug class (USD Million) 2018 - 2030
Table 64 Brazil psoriatic arthritis treatment market, by type (USD Million) 2018 - 2030
Table 65 Brazil surgical ablation market, by route of administration (USD Million) 2018 - 2030
Table 66 Argentina psoriatic arthritis treatment market, by drug class (USD Million) 2018 - 2030
Table 67 Argentina psoriatic arthritis treatment market, by type (USD Million) 2018 - 2030
Table 68 Argentina surgical ablation market, by route of administration (USD Million) 2018 - 2030
Table 69 MEA psoriatic arthritis treatment market, by region (USD Million) 2018 - 2030
Table 70 MEA psoriatic arthritis treatment market, by drug class (USD Million) 2018 - 2030
Table 71 MEA psoriatic arthritis treatment market, by type (USD Million) 2018 - 2030
Table 72 MEA psoriatic arthritis treatment market, by route of administration (USD Million) 2018 - 2030
Table 73 South Africa psoriatic arthritis treatment market, by drug class (USD Million) 2018 - 2030
Table 74 South Africa psoriatic arthritis treatment market, by type (USD Million) 2018 - 2030
Table 75 South Africa psoriatic arthritis treatment market, by route of administration (USD Million) 2018 - 2030
Table 76 Saudi Arabia psoriatic arthritis treatment market, by drug class (USD Million) 2018 - 2030
Table 77 Saudi Arabia psoriatic arthritis treatment market, by type (USD Million) 2018 - 2030
Table 78 Saudi Arabia psoriatic arthritis treatment market, by route of administration (USD Million) 2018 - 2030
Table 79 UAE psoriatic arthritis treatment market, by drug class (USD Million) 2018 - 2030
Table 80 UAE psoriatic arthritis treatment market, by type (USD Million) 2018 - 2030
Table 81 UAE psoriatic arthritis treatment market, by route of administration (USD Million) 2018 - 2030

List of Figures
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Primary interviews
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 QFD modeling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 Psoriatic arthritis treatment market: market outlook
Fig. 10 Psoriatic arthritis treatment competitive insights
Fig. 11 Parent market outlook
Fig. 12 Related/ancillary market outlook
Fig. 13 Penetration and growth prospect mapping
Fig. 14 Industry value chain analysis
Fig. 15 Psoriatic arthritis treatment market driver impact
Fig. 16 Psoriatic arthritis treatment market restraint impact
Fig. 17 Psoriatic arthritis treatment market strategic initiatives analysis
Fig. 18 Psoriatic arthritis treatment market: Drug Class movement analysis
Fig. 19 Psoriatic arthritis treatment market: Drug Class outlook and key takeaways
Fig. 20 NSAIDs market estimates and forecast, 2018 - 2030
Fig. 21 DMARDs market estimates and forecast, 2018 - 2030
Fig. 22 Biologics market estimates and forecast, 2018 - 2030
Fig. 23 Others market estimates and forecast, 2018 - 2030
Fig. 24 Psoriatic arthritis treatment Market: Type movement Analysis
Fig. 25 Psoriatic arthritis treatment market: Type outlook and key takeaways
Fig. 26 Prescriptions market estimates and forecasts, 2018 - 2030
Fig. 27 OTC market estimates and forecasts,2018 - 2030
Fig. 28 Psoriatic arthritis treatment market: Route of Administration movement analysis
Fig. 29 Psoriatic arthritis treatment market: Route of Administration outlook and key takeaways
Fig. 30 Topical market estimates and forecasts, 2018 - 2030
Fig. 31 Oral market estimates and forecasts,2018 - 2030
Fig. 32 Injectable market estimates and forecasts, 2018 - 2030
Fig. 33 Global psoriatic arthritis treatment market: Regional movement analysis
Fig. 34 Global psoriatic arthritis treatment market: Regional outlook and key takeaways
Fig. 35 North America market estimates and forecasts, 2018 - 2030
Fig. 36 U.S. market estimates and forecasts, 2018 - 2030
Fig. 37 Canada market estimates and forecasts, 2018 - 2030
Fig. 38 Mexico market estimates and forecasts, 2018 - 2030
Fig. 39 Europe market estimates and forecasts, 2018 - 2030
Fig. 40 UK market estimates and forecasts, 2018 - 2030
Fig. 41 Germany market estimates and forecasts, 2018 - 2030
Fig. 42 France market estimates and forecasts, 2018 - 2030
Fig. 43 Italy market estimates and forecasts, 2018 - 2030
Fig. 44 Spain market estimates and forecasts, 2018 - 2030
Fig. 45 Asia Pacific market estimates and forecasts, 2018 - 2030
Fig. 46 China market estimates and forecasts, 2018 - 2030
Fig. 47 Japan market estimates and forecasts, 2018 - 2030
Fig. 48 India market estimates and forecasts, 2018 - 2030
Fig. 49 South Korea market estimates and forecasts, 2018 - 2030
Fig. 50 Australia market estimates and forecasts, 2018 - 2030
Fig. 51 Latin America market estimates and forecasts, 2018 - 2030
Fig. 52 Brazil market estimates and forecasts, 2018 - 2030
Fig. 53 Argentina market estimates and forecasts, 2018 - 2030
Fig. 54 Middle East and Africa market estimates and forecasts, 2018 - 2030
Fig. 55 South Africa market estimates and forecasts, 2018 - 2030
Fig. 56 Saudi Arabia market estimates and forecasts, 2018 - 2030
Fig. 57 UAE market estimates and forecasts, 2018 - 2030